Orbitrex Peptides
Finnrick has tested 16 samples from Orbitrex Peptides across 3 products.
Finnrick Vendor Profile
Orbitrex Peptides
Tracking 3 products
16 total samples tested
Last test 2 Mar 2026
Take Action
Test My Sample
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| GHK-Cu | 2 | 25 Oct 2025 | 27 Oct 2025 | |||||
| Retatrutide | 8 | 7 Oct 2025 | 2 Mar 2026 | |||||
| Tirzepatide | 3 | 23 Nov 2025 | 13 Feb 2026 | |||||
Most recent Orbitrex Peptides tests
Samples are tested in commercial labs
16
tests
3
products
Scores
AVGMINMAX
First
7 Oct 2025
Last
2 Mar 2026
| Quantity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Batch | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 2 Mar 2026 | Retatrutide | View | 10mg | (no batch claim) | 11.5mg | +15.0% | 99.90% | 3G101125 | Black Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 13 Feb 2026 | Tirzepatide | View | 10mg | 11.4mg | 11.4mg | +0.3% | 99.69% | 2ZG101125 | Yellow Label / Silver Crimp / Yellow Cap | Lab E | Public | |
| 13 Feb 2026 | Retatrutide | View | 10mg | 11.3mg | 9.9mg | -12.2% | 99.90% | 3G101125 | Black Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 24 Nov 2025 | Tirzepatide | View | 10mg | ⚠️ Sample does not contain Tirzepatide | 2GTZ1019625 | Yellow Label / Silver Crimp / Yellow Cap | Lab A | Vendor | ||||
| 24 Nov 2025 | Tirzepatide | View | 10mg | 11.6mg | 11.05mg | -5.0% | 99.58% | 2GTZ1019625 | Yellow Label / Silver Crimp / Yellow Cap | Lab A | Vendor | |
| 24 Nov 2025 | Retatrutide | View | 20mg | ⚠️ Sample does not contain Retatrutide | 3G201125 | Black Label / Silver Crimp / Green Cap | Lab A | Vendor | ||||
| 23 Nov 2025 | Retatrutide | View | 20mg | 23.1mg | 21.98mg | -5.0% | 99.87% | 3G201125 | Black Label / Silver Crimp / Green Cap | Lab A | Vendor | |
Corrections
- 9 Mar 2026: Retatrutide
- Sample p4bqre8: original COA reported purity of 97.83%. Upon vendor objection, lab investigated and found the automated integration routine picked up noise as peaks and erroneously integrated it. Manual revision led to updated calculations for purity and quantity. The lab issued an updated COA. This sample's test score changed from 3.7 to 7.0, and the Finnrick Rating for Orbitrex Retatrutide changed from D to A.
- 9 Mar 2026: Tirzepatide
- Sample nwwrwhu: original COA reported purity of 92.83%. Upon vendor objection, lab investigated and found the automated integration routine picked up noise as peaks and erroneously integrated it. Manual revision led to updated calculations for purity and quantity. The lab issued an updated COA. This sample's test score changed from 5.9 to 9.0, and the Finnrick Rating for Orbitrex Tirzepatide changed from B to A.